<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0038">
 <label>38</label>
 <element-citation publication-type="journal" id="sbref0038">
  <person-group person-group-type="author">
   <name>
    <surname>Altenburg</surname>
    <given-names>AF</given-names>
   </name>
   <name>
    <surname>Kreijtz</surname>
    <given-names>JHCM</given-names>
   </name>
   <name>
    <surname>de Vries</surname>
    <given-names>RD</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Fux</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Rimmelzwaan</surname>
    <given-names>GF</given-names>
   </name>
  </person-group>
  <article-title>Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases</article-title>
  <source>Viruses</source>
  <volume>6</volume>
  <year>2014</year>
  <fpage>2735</fpage>
  <lpage>2761</lpage>
  <pub-id pub-id-type="pmid">25036462</pub-id>
 </element-citation>
</ref>
